Lindsey Rolfe
Overview
Lindsey Rolfe received an average of $2M in total compensation, including $470K in salary, at Clovis Oncology from 2015 to 2021.
2021Clovis OncologyEVP of Clinical Development and Pharmacovigilance and Chief Medical Officer
2020Clovis OncologyEVP of Clinical Development and Pharmacovigilance and Chief Medical Officer
2019Clovis OncologyEVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer
2018Clovis OncologyEVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer
2017Clovis OncologyEVP of Clinical and Development and Pharmacovigilance and Chief Medical Officer
2016Clovis OncologyEVP of Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer
2015Clovis OncologyEVP of Clinical and Pre-Clinical Development and Pharmacovigilance and Chief Medical Officer
Source: SEC filings on April 27, 2022, April 28, 2021, April 24, 2020, April 26, 2019, April 27, 2018, and April 26, 2017.
Related executives
We found eight more executives who work or worked at Clovis Oncology.
Patrick Mahaffy
Clovis Oncology
Chief Executive Officer
Gillian Ivers-Read
Clovis Oncology
EVP and Chief Regulatory Officer
Paul Gross
Clovis Oncology
General Counsel
Daniel Muehl
Clovis Oncology
Chief Financial Officer
C Hooks
Clovis Oncology
Former Senior VP and Chief Commercial Officer
Erle Mast
Clovis Oncology
Chief Financial Officer
Andrew Allen
Clovis Oncology
Chief Medical Officer
Steven Hoerter
Clovis Oncology
EVP and Chief Commercial Officer
News
Clovis Oncology CEO Patrick Mahaffy's 2021 pay slips 18% to $2.6M
April 27, 2022
Clovis Oncology CEO Patrick Mahaffy's 2020 pay falls 53% to $3.2M
April 28, 2021
Clovis Oncology CEO Patrick Mahaffy's 2019 pay rises 10% to $6.9M
April 24, 2020
Clovis Oncology CEO Patrick Mahaffy's 2018 pay falls 28% to $6.3M
April 26, 2019